Kahn Swick & Foti, LLC and former Louisiana Attorney General Charles C. Foti, Jr. remind investors with losses in excess of $100,000 on Molina Healthcare securities acquired between February 5, 2025 and July 23, 2025 that they have until December 2, 2025 to file lead plaintiff applications in the class action lawsuit.
The lawsuit, Hindlemann v. Molina Healthcare, Inc., alleges the company and certain executives failed to disclose material information during the class period.
On July 23, 2025, Molina reported Q2 2025 GAAP net income of $4.75 per diluted share (down 8% year-over-year) and cut its full-year 2025 adjusted EPS guidance to no less than $19.00 per diluted share.
Following this announcement, Molina’s shares fell $32.03 (16.84%) to close at $158.22 on July 24, 2025, on unusually heavy trading volume.

1 day ago

Press Release

Molina Healthcare prices $850 M 6.500% senior notes due 2031

MOH

Debt Issuance

Molina priced $850 million aggregate principal of 6.500% senior notes due February 15, 2031 in a private Rule 144A/Reg S offering, with closing expected November 20, 2025.
The unsecured notes bear interest at 6.500% per annum, payable semi-annually on February 15 and August 15 beginning August 15, 2026, and are not guaranteed by subsidiaries.
Net proceeds are estimated at $838 million, intended for general corporate purposes, including repayment of existing delayed draw term loans.

2 days ago

8-K

Molina Healthcare proposes $750M senior notes offering

MOH

Debt Issuance

Molina Healthcare intends to privately offer $750 million aggregate principal amount of senior notes due 2031, subject to market and customary closing conditions.
The notes will not be guaranteed by subsidiaries; interest rate, offering price and other terms will be negotiated, with net proceeds used to repay outstanding delayed draw term loans under its existing credit agreement.
Upon closing, the company plans to terminate its existing credit facility and replace it with a new revolving credit facility featuring substantially similar terms but with amended, more favorable covenants.
The new facility is fully committed, will be undrawn at close, and remain fully available for general corporate purposes, including working capital needs, acquisitions and capital expenditures.

3 days ago

8-K

Molina Healthcare awarded Florida Medicaid managed care contract

MOH

New Projects/Investments

On Nov. 14, 2025, Molina Healthcare, Inc. (NYSE: MOH) was selected by the Florida Agency for Health Care Administration to provide statewide Medicaid Managed Care (SMMC) and Children’s Health Insurance Program services under Title XIX and Title XXI Children’s Medical Services (CMS) Program.
Molina will be the sole provider, serving approximately 120,000 enrollees.
In calendar year 2025, premiums under the contract are expected to total $5 billion, with the contract term running through Dec. 31, 2030.

6 days ago

8-K

Molina Healthcare shareholder alert: lead plaintiff deadline set for Dec 2, 2025

MOH

Legal Proceedings

Kahn Swick & Foti reminds investors with losses exceeding $100,000 from purchases of Molina (NYSE: MOH) securities between February 5 and July 23, 2025 to file lead plaintiff motions by December 2, 2025.
The suit alleges Molina failed to disclose material information during the class period, following its Q2 2025 report showing GAAP net income of $4.75 per diluted share (down 8% YoY) and a revised full-year adjusted EPS guidance of no less than $19.00.
On July 24, 2025, Molina’s share price dropped $32.03 (16.84%), closing at $158.22 per share on heavy volume.

Nov 12, 2025, 3:41 AM

Press Release

Molina Healthcare faces shareholder class action over alleged misstatements

MOH

Legal Proceedings

Bragar Eagel & Squire, P.C. has filed a class action on behalf of Molina Healthcare investors for the Class Period Feb. 5, 2025 to July 23, 2025, with lead plaintiff applications due by Dec. 2, 2025.
The complaint alleges Molina failed to disclose material adverse facts about its medical cost trend assumptions, a dislocation between premium rates and medical cost trends, and dependency on low utilization of key services, creating a substantial risk of FY 2025 guidance cuts and rendering prior public statements misleading.
Investors are reminded to contact Bragar Eagel & Squire to petition the court to serve as lead plaintiff before the deadline.

Nov 10, 2025, 9:36 PM

Press Release

Molina Healthcare investigated for alleged securities fraud

MOH

Legal Proceedings

Grabar Law Office is probing whether Molina Healthcare (NYSE: MOH) officers and directors breached fiduciary duties by failing to disclose material adverse facts on medical cost trends and misaligned premium rates.
The complaint alleges undisclosed dependence on low utilization of behavioral health, pharmacy, and inpatient/outpatient services, and an impending cut to FY2025 financial guidance.
Eligible shareholders who bought MOH shares before February 5, 2025 and still hold them can seek corporate reforms, fund recovery, and incentive awards at no cost.

Nov 10, 2025, 2:42 PM

Press Release

Molina Healthcare under investigation after earnings guidance cuts

MOH

Legal Proceedings

Guidance Update

Securities law firm Faruqi & Faruqi, LLP has launched an investigation into potential securities law violations at Molina Healthcare, urging affected investors to contact them directly.
Molina’s July 7, 2025 Q2 release revealed $5.50 adjusted EPS, prompted a 10.2% downward revision of its full-year 2025 adjusted EPS guidance to $21.50–$22.50, and saw its stock drop 2.9%.
On July 23, 2025 Molina further cut its guidance, reporting Q2 GAAP EPS of $4.75 (−8% YoY), lowering full-year 2025 adjusted EPS to ≥$19.00 and GAAP net income guidance to $912 million (−27%), triggering a 16.84% stock decline.

Nov 6, 2025, 4:52 PM

Press Release

Molina Healthcare shareholders reminded of class action lead plaintiff deadline

MOH

Legal Proceedings

Investors who acquired Molina Healthcare securities between February 5 and July 23, 2025 have until December 2, 2025 to file lead plaintiff applications in the class action lawsuit.
The lawsuit alleges Molina failed to disclose material information when it reported Q2 2025 GAAP net income of $4.75 per diluted share (down 8% year-over-year) and cut full-year adjusted earnings guidance to no less than $19.00 per diluted share on July 23, 2025.
Following the guidance cut, Molina’s share price fell $32.03 (16.84%) to $158.22 on July 24, 2025.
The case is Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461, pending in the U.S. District Court for the Central District of California.

Nov 5, 2025, 3:44 AM

Press Release

Molina Healthcare sued for alleged misleading medical cost disclosures

MOH

Legal Proceedings

Bragar Eagel & Squire reminds shareholders of a class action against Molina Healthcare (NYSE: MOH) covering Class Period: February 5, 2025 to July 23, 2025, with Lead Plaintiff Deadline: December 2, 2025.
Complaint alleges failure to disclose adverse facts concerning medical cost trend assumptions and a dislocation between premium rates and cost trends.
Plaintiffs claim Molina’s near-term growth depended on underutilization of behavioral health, pharmacy, and other services, and that FY2025 guidance was likely to be cut, rendering positive statements materially misleading.

Nov 4, 2025, 10:40 PM

Press Release

Filings & Transcripts

View All Documents

Recent SEC filings and earnings call transcripts for MOH.

No recent filings or transcripts found for MOH.